Pharma Mylan Hungary’s Tamas Uri discusses transitioning into both a branded and generic business dedicated company, Mylan’s expansion in Hungary, and how the pharmaceutical industry can be a key player in improving the extremely low health literacy rates in the country. As an introduction to our readers could you please provide some insight…
Pharma Sébastien Lucot, General Manager of Uriage, explains the company’s product base, their line of thermal water based products and the healing properties of Uriage water from the French Alps. Lucot expands on Uriage’s growing presence in France, Europe and Asia as well as their new branding strategy to grow their…
Pharma 3PL player BOMI Group went public via an IPO in June 2015. VP & CFO Marco Ruini discusses the reasons behind this Italian family company’s decision to go public, as well as its ambitious expansion strategy. How would you assess the success of the IPO that took place last year? This IPO…
Pharma The managing director of CSL Behring Hungary, Attila Lukács, discusses the company’s recent establishment in Hungary, the strategic benefits the country offers, as well as his experience starting an affiliate from scratch. He also shares his thoughts on the recent expansion of CSL Plasma in Hungary and his vision for…
Pharma Bernard Fraisse of Fareva, France’s leading CMO, discusses growth, international expansion, loyalty to France, dedication to clients, and commitment to providing high quality products. Many have predicted that pharma manufacturing in France will soon die out, but instead we have seen a shift from manufacturing of large pharmaceutical groups to…
Pharma Eric Goupil reveals how the global CMO market has expanded considerably over recent years, with a move towards a more strategic mind-set in the pharmaceutical industry. Unither´s business model is to focus on unit-dose products and in particular, sterile unit-dose using Blow-Fill-Seal (BFS) technology and today they are competing on…
Pharma The president and CEO of AREVA Med, the medical subsidiary of AREVA Group, the biggest nuclear company in the world, discusses the circumstances that inspired AREVA’s foray into nuclear medicine, one of the most interesting new fields in medicine today. He outlines his company’s philosophy of simplicity and excellence, his…
sales UCB has transformed into a specialty care pharma which focuses on bringing solutions to patients suffering from severe chronic diseases. The vice president and region head for Americas discusses how the company re-entered key markets in the Latin American space to drive future growth, how the company’s three flagships products…
See our Cookie Privacy Policy Here